Company / Inventory
Tarsus Pharmaceuticals, Inc. Inventory History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$4.4M
FY2025
5-year range
$2.6M / $4.4M
FY2023-FY2025
Trend
+66.9%
vs FY2024
Sector context
#97 of 105
Health Care
What the data says
Among 105 Health Care companies, Tarsus Pharmaceuticals, Inc. is in the bottom 8% for inventory. Improved from $3M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025.
Improved from $3M to $4M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 105This company $4.4M Sector average $885.3M
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, inventory increased 66.9% year-over-year.
- Ranks #97 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.4M | +66.9% |
| FY2024 | $2.6M | -15.7% |
| FY2023 | $3.1M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026